Global Bladder Cancer Therapeutics Market by Treatment Type (Chemotherapy, Gene Therapy, Immunotherapy), Bladder Cancer Type (Invasive Bladder Cancer, Squamous Cell Bladder Cancer, Superficial Bladder Cancer), End-User - Forecast 2024-2030- Product Image

Sale

Global Bladder Cancer Therapeutics Market by Treatment Type (Chemotherapy, Gene Therapy, Immunotherapy), Bladder Cancer Type (Invasive Bladder Cancer, Squamous Cell Bladder Cancer, Superficial Bladder Cancer), End-User - Forecast 2024-2030

Report
185 Pages
March 2024
Region: Global
360iResearch™
ID: 5887289

UP TO €853EUR$875USD£729GBP OFF until Dec 31^st 2024

The Bladder Cancer Therapeutics Market size was estimated at USD 5.21 billion in 2023, USD 5.56 billion in 2024, and is expected to grow at a CAGR of 7.23% to reach USD 8.49 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Bladder Cancer Therapeutics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Bladder Cancer Therapeutics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Bladder Cancer Therapeutics Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Agilent Technologies, Inc., Amneal Pharmaceuticals LLC, AroCell AB, Bristol-Myers Squibb Company, Eisai Co., Ltd., Eli Lilly and Company, Endo International PLC, F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Merck KGaA, Olympus Corporation, Pacific Edge Ltd., Pfizer Inc., Spectrum Pharmaceuticals, Inc., and UroGen Pharma Ltd.

Market Segmentation & Coverage

This research report categorizes the Bladder Cancer Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

Treatment Type
- Chemotherapy
- Gene Therapy
- Immunotherapy
- Radiation therapy
- Surgery
- Targeted Therapy
Bladder Cancer Type
- Invasive Bladder Cancer
- Squamous Cell Bladder Cancer
- Superficial Bladder Cancer
- Transitional Cell Bladder Cancer
End-User
- Ambulatory Surgical Centers
- Hospitals
- Specialty Cancer Clinics

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

What is the market size and forecast of the Bladder Cancer Therapeutics Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Bladder Cancer Therapeutics Market?
What are the technology trends and regulatory frameworks in the Bladder Cancer Therapeutics Market?
What is the market share of the leading vendors in the Bladder Cancer Therapeutics Market?
Which modes and strategic moves are suitable for entering the Bladder Cancer Therapeutics Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Bladder Cancer Therapeutics Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidences of bladder cancer across the world
5.1.1.2. Growing awareness about bladder cancer and timely treatment
5.1.1.3. Increasing development of new cancer-targeting drugs
5.1.2. Restraints
5.1.2.1. High cost associated with bladder cancer treatment
5.1.3. Opportunities
5.1.3.1. Incorporation of machine learning (ML) and artificial intelligence (AI) in bladder cancer therapeutics
5.1.3.2. Ongoing development of targeted therapies and personalized medicine for bladder cancer treatment
5.1.4. Challenges
5.1.4.1. Limited availability of skilled healthcare professionals for administering complex treatment
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Bladder Cancer Therapeutics Market, by Treatment Type

6.1. Introduction
6.2. Chemotherapy
6.3. Gene Therapy
6.4. Immunotherapy
6.5. Radiation therapy
6.6. Surgery
6.7. Targeted Therapy

7. Bladder Cancer Therapeutics Market, by Bladder Cancer Type

7.1. Introduction
7.2. Invasive Bladder Cancer
7.3. Squamous Cell Bladder Cancer
7.4. Superficial Bladder Cancer
7.5. Transitional Cell Bladder Cancer

8. Bladder Cancer Therapeutics Market, by End-User

8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Hospitals
8.4. Specialty Cancer Clinics

9. Americas Bladder Cancer Therapeutics Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Bladder Cancer Therapeutics Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Bladder Cancer Therapeutics Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

13.1. Key Company Profiles
13.1.1. AbbVie Inc.
13.1.2. Agilent Technologies, Inc.
13.1.3. Amneal Pharmaceuticals LLC
13.1.4. AroCell AB
13.1.5. Bristol-Myers Squibb Company
13.1.6. Eisai Co., Ltd.
13.1.7. Eli Lilly and Company
13.1.8. Endo International PLC
13.1.9. F. Hoffmann-La Roche Ltd.
13.1.10. GlaxoSmithKline PLC
13.1.11. Hikma Pharmaceuticals PLC
13.1.12. Johnson & Johnson Services, Inc.
13.1.13. Koninklijke Philips N.V.
13.1.14. Merck KGaA
13.1.15. Olympus Corporation
13.1.16. Pacific Edge Ltd.
13.1.17. Pfizer Inc.
13.1.18. Spectrum Pharmaceuticals, Inc.
13.1.19. UroGen Pharma Ltd.
13.2. Key Product Portfolio

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. BLADDER CANCER THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 2. BLADDER CANCER THERAPEUTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. BLADDER CANCER THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. BLADDER CANCER THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. BLADDER CANCER THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. BLADDER CANCER THERAPEUTICS MARKET DYNAMICS
FIGURE 7. BLADDER CANCER THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
FIGURE 8. BLADDER CANCER THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. BLADDER CANCER THERAPEUTICS MARKET SIZE, BY BLADDER CANCER TYPE, 2023 VS 2030 (%)
FIGURE 10. BLADDER CANCER THERAPEUTICS MARKET SIZE, BY BLADDER CANCER TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. BLADDER CANCER THERAPEUTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. BLADDER CANCER THERAPEUTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BLADDER CANCER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS BLADDER CANCER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BLADDER CANCER THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES BLADDER CANCER THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC BLADDER CANCER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC BLADDER CANCER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BLADDER CANCER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BLADDER CANCER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. BLADDER CANCER THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. BLADDER CANCER THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. BLADDER CANCER THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. BLADDER CANCER THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BLADDER CANCER THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. BLADDER CANCER THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 6. BLADDER CANCER THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. BLADDER CANCER THERAPEUTICS MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. BLADDER CANCER THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. BLADDER CANCER THERAPEUTICS MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. BLADDER CANCER THERAPEUTICS MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. BLADDER CANCER THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. BLADDER CANCER THERAPEUTICS MARKET SIZE, BY BLADDER CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 13. BLADDER CANCER THERAPEUTICS MARKET SIZE, BY INVASIVE BLADDER CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. BLADDER CANCER THERAPEUTICS MARKET SIZE, BY SQUAMOUS CELL BLADDER CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. BLADDER CANCER THERAPEUTICS MARKET SIZE, BY SUPERFICIAL BLADDER CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. BLADDER CANCER THERAPEUTICS MARKET SIZE, BY TRANSITIONAL CELL BLADDER CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. BLADDER CANCER THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 18. BLADDER CANCER THERAPEUTICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. BLADDER CANCER THERAPEUTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. BLADDER CANCER THERAPEUTICS MARKET SIZE, BY SPECIALTY CANCER CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS BLADDER CANCER THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS BLADDER CANCER THERAPEUTICS MARKET SIZE, BY BLADDER CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS BLADDER CANCER THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS BLADDER CANCER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA BLADDER CANCER THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA BLADDER CANCER THERAPEUTICS MARKET SIZE, BY BLADDER CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA BLADDER CANCER THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL BLADDER CANCER THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL BLADDER CANCER THERAPEUTICS MARKET SIZE, BY BLADDER CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL BLADDER CANCER THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 31. CANADA BLADDER CANCER THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 32. CANADA BLADDER CANCER THERAPEUTICS MARKET SIZE, BY BLADDER CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 33. CANADA BLADDER CANCER THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 34. MEXICO BLADDER CANCER THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 35. MEXICO BLADDER CANCER THERAPEUTICS MARKET SIZE, BY BLADDER CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 36. MEXICO BLADDER CANCER THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES BLADDER CANCER THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES BLADDER CANCER THERAPEUTICS MARKET SIZE, BY BLADDER CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES BLADDER CANCER THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES BLADDER CANCER THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC BLADDER CANCER THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC BLADDER CANCER THERAPEUTICS MARKET SIZE, BY BLADDER CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC BLADDER CANCER THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. ASIA-PACIFIC BLADDER CANCER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA BLADDER CANCER THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 46. AUSTRALIA BLADDER CANCER THERAPEUTICS MARKET SIZE, BY BLADDER CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 47. AUSTRALIA BLADDER CANCER THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. CHINA BLADDER CANCER THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 49. CHINA BLADDER CANCER THERAPEUTICS MARKET SIZE, BY BLADDER CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 50. CHINA BLADDER CANCER THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. INDIA BLADDER CANCER THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 52. INDIA BLADDER CANCER THERAPEUTICS MARKET SIZE, BY BLADDER CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 53. INDIA BLADDER CANCER THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA BLADDER CANCER THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 55. INDONESIA BLADDER CANCER THERAPEUTICS MARKET SIZE, BY BLADDER CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 56. INDONESIA BLADDER CANCER THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. JAPAN BLADDER CANCER THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 58. JAPAN BLADDER CANCER THERAPEUTICS MARKET SIZE, BY BLADDER CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 59. JAPAN BLADDER CANCER THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA BLADDER CANCER THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 61. MALAYSIA BLADDER CANCER THERAPEUTICS MARKET SIZE, BY BLADDER CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 62. MALAYSIA BLADDER CANCER THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES BLADDER CANCER THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 64. PHILIPPINES BLADDER CANCER THERAPEUTICS MARKET SIZE, BY BLADDER CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 65. PHILIPPINES BLADDER CANCER THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE BLADDER CANCER THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 67. SINGAPORE BLADDER CANCER THERAPEUTICS MARKET SIZE, BY BLADDER CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 68. SINGAPORE BLADDER CANCER THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA BLADDER CANCER THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 70. SOUTH KOREA BLADDER CANCER THERAPEUTICS MARKET SIZE, BY BLADDER CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 71. SOUTH KOREA BLADDER CANCER THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN BLADDER CANCER THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 73. TAIWAN BLADDER CANCER THERAPEUTICS MARKET SIZE, BY BLADDER CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 74. TAIWAN BLADDER CANCER THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. THAILAND BLADDER CANCER THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 76. THAILAND BLADDER CANCER THERAPEUTICS MARKET SIZE, BY BLADDER CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 77. THAILAND BLADDER CANCER THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM BLADDER CANCER THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 79. VIETNAM BLADDER CANCER THERAPEUTICS MARKET SIZE, BY BLADDER CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 80. VIETNAM BLADDER CANCER THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA BLADDER CANCER THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA BLADDER CANCER THERAPEUTICS MARKET SIZE, BY BLADDER CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA BLADDER CANCER THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA BLADDER CANCER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 85. DENMARK BLADDER CANCER THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 86. DENMARK BLADDER CANCER THERAPEUTICS MARKET SIZE, BY BLADDER CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 87. DENMARK BLADDER CANCER THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. EGYPT BLADDER CANCER THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 89. EGYPT BLADDER CANCER THERAPEUTICS MARKET SIZE, BY BLADDER CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 90. EGYPT BLADDER CANCER THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. FINLAND BLADDER CANCER THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 92. FINLAND BLADDER CANCER THERAPEUTICS MARKET SIZE, BY BLADDER CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 93. FINLAND BLADDER CANCER THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. FRANCE BLADDER CANCER THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 95. FRANCE BLADDER CANCER THERAPEUTICS MARKET SIZE, BY BLADDER CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 96. FRANCE BLADDER CANCER THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. GERMANY BLADDER CANCER THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 98. GERMANY BLADDER CANCER THERAPEUTICS MARKET SIZE, BY BLADDER CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 99. GERMANY BLADDER CANCER THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL BLADDER CANCER THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 101. ISRAEL BLADDER CANCER THERAPEUTICS MARKET SIZE, BY BLADDER CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 102. ISRAEL BLADDER CANCER THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. ITALY BLADDER CANCER THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 104. ITALY BLADDER CANCER THERAPEUTICS MARKET SIZE, BY BLADDER CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 105. ITALY BLADDER CANCER THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS BLADDER CANCER THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 107. NETHERLANDS BLADDER CANCER THERAPEUTICS MARKET SIZE, BY BLADDER CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 108. NETHERLANDS BLADDER CANCER THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA BLADDER CANCER THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 110. NIGERIA BLADDER CANCER THERAPEUTICS MARKET SIZE, BY BLADDER CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 111. NIGERIA BLADDER CANCER THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 112. NORWAY BLADDER CANCER THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 113. NORWAY BLADDER CANCER THERAPEUTICS MARKET SIZE, BY BLADDER CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 114. NORWAY BLADDER CANCER THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. POLAND BLADDER CANCER THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 116. POLAND BLADDER CANCER THERAPEUTICS MARKET SIZE, BY BLADDER CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 117. POLAND BLADDER CANCER THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. QATAR BLADDER CANCER THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 119. QATAR BLADDER CANCER THERAPEUTICS MARKET SIZE, BY BLADDER CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 120. QATAR BLADDER CANCER THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA BLADDER CANCER THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA BLADDER CANCER THERAPEUTICS MARKET SIZE, BY BLADDER CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA BLADDER CANCER THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA BLADDER CANCER THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 125. SAUDI ARABIA BLADDER CANCER THERAPEUTICS MARKET SIZE, BY BLADDER CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 126. SAUDI ARABIA BLADDER CANCER THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA BLADDER CANCER THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA BLADDER CANCER THERAPEUTICS MARKET SIZE, BY BLADDER CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 129. SOUTH AFRICA BLADDER CANCER THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. SPAIN BLADDER CANCER THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 131. SPAIN BLADDER CANCER THERAPEUTICS MARKET SIZE, BY BLADDER CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 132. SPAIN BLADDER CANCER THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN BLADDER CANCER THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 134. SWEDEN BLADDER CANCER THERAPEUTICS MARKET SIZE, BY BLADDER CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 135. SWEDEN BLADDER CANCER THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND BLADDER CANCER THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 137. SWITZERLAND BLADDER CANCER THERAPEUTICS MARKET SIZE, BY BLADDER CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 138. SWITZERLAND BLADDER CANCER THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. TURKEY BLADDER CANCER THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 140. TURKEY BLADDER CANCER THERAPEUTICS MARKET SIZE, BY BLADDER CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 141. TURKEY BLADDER CANCER THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES BLADDER CANCER THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES BLADDER CANCER THERAPEUTICS MARKET SIZE, BY BLADDER CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES BLADDER CANCER THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM BLADDER CANCER THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM BLADDER CANCER THERAPEUTICS MARKET SIZE, BY BLADDER CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM BLADDER CANCER THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 148. BLADDER CANCER THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 149. BLADDER CANCER THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 150. BLADDER CANCER THERAPEUTICS MARKET LICENSE & PRICING

Companies Mentioned

AbbVie Inc.
Agilent Technologies, Inc.
Amneal Pharmaceuticals LLC
AroCell AB
Bristol-Myers Squibb Company
Eisai Co., Ltd.
Eli Lilly and Company
Endo International PLC
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline PLC
Hikma Pharmaceuticals PLC
Johnson & Johnson Services, Inc.
Koninklijke Philips N.V.
Merck KGaA
Olympus Corporation
Pacific Edge Ltd.
Pfizer Inc.
Spectrum Pharmaceuticals, Inc.
UroGen Pharma Ltd.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	185
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 5.56 Billion
Forecasted Market Value ( USD ) by 2030	$ 8.49 Billion
Compound Annual Growth Rate	7.2%
Regions Covered	Global
No. of Companies Mentioned	19

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3291EUR$3,374USD£2,810GBP €3657EUR$3,749USD£3,122GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4169EUR$4,274USD£3,560GBP €4632EUR$4,749USD£3,955GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5047EUR$5,174USD£4,309GBP €5608EUR$5,749USD£4,788GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5925EUR$6,074USD£5,059GBP €6583EUR$6,749USD£5,621GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7681EUR$7,874USD£6,558GBP €8534EUR$8,749USD£7,286GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects

The report addresses key questions such as

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Bladder Cancer Therapeutics: Global Strategic Business Report

Non-Muscle Invasive Bladder Cancer (NMIBC) Market Insight, Epidemiology and Market Forecast - 2034

Non-muscle Invasive Bladder Cancer Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Non Muscle Invasive Bladder Cancer - Pipeline Insight, 2024

Bladder Cancer Therapeutics and Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

About the Bladder Cancer Drugs Market